SYM Financial Corp
BIIB icon

SYM Financial Corp’s Biogen BIIB Stock Holding History

SYM Financial Corp’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$273K Buy
1,208
+22
+2% +$4.67K 0.02% 313
2026
Q2 		$256K Buy
1,186
+36
+3% +$6.89K 0.02% 303
2026
Q1 		$211K Buy
+1,150
New +$212K 0.02% 301
2025
Q4 		– Sell
-1,695
Closed -$237K – 425
2025
Q3 		$237K Buy
+1,695
New +$229K 0.03% 268

Other funds holding BIIB

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

SYM Financial Corp's BIIB Position: Q3 2026 in Review

SYM Financial Corp increased its Biogen (BIIB) stake by 1.9% in Q3 2026, buying an estimated $4.67K and bringing the position to 1,208 shares worth $273K. The position accounts for 0.02% of the portfolio, ranked #313.

SYM Financial Corp first reported a position in BIIB in Q3 2025 and has held it in 4 quarters since. 580 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • SYM Financial Corp held 1,208 shares of Biogen worth $273K as of Q3 2026.
  • SYM Financial Corp bought 22 Biogen shares in Q3 2026, an estimated $4.67K.
  • Biogen made up 0.02% of SYM Financial Corp's portfolio in Q3 2026, its #313 holding.
  • SYM Financial Corp first reported a position in Biogen in Q3 2025 and has held it in 4 quarters since.
  • 580 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on SYM Financial Corp's 13F filing for Q3 2026, filed 26 Oct 2026.